Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19773176rdf:typepubmed:Citationlld:pubmed
pubmed-article:19773176lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:19773176lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:19773176lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:19773176lifeskim:mentionsumls-concept:C0030230lld:lifeskim
pubmed-article:19773176lifeskim:mentionsumls-concept:C0039946lld:lifeskim
pubmed-article:19773176lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:19773176pubmed:issue20lld:pubmed
pubmed-article:19773176pubmed:dateCreated2009-10-6lld:pubmed
pubmed-article:19773176pubmed:abstractTextThe palladium(II) complexes [Pd(2Bz4oT)Cl], [Pd(2Bz4mT)Cl], and [Pd(2Bz4pT)Cl] were prepared with N(4)-ortho- (H2Bz4oT) N(4)-meta- (H2Bz4mT) and N(4)-para- (H2Bz4pT) tolyl-thiosemicarbazones derived from 2-benzoylpyridine. The free thiosemicarbazones proved to be highly cytotoxic against Jurkat, HL60 and the resistant HL60.Bcl-X(L) leukemia cell lines at nanomolar concentrations, but were much less cytotoxic to HepG2human hepatoma cells. Upon coordination to palladium(II) the cytotoxic activity against all studied cell lines decreases. However, the high cytotoxicity of the free thiosemicarbazones against leukemia, together with their hepatotoxic profile similar to that of cisplatin suggest that N(4)-tolyl thiosemicarbazones have potential as chemotherapeutic drug candidates.lld:pubmed
pubmed-article:19773176pubmed:languageenglld:pubmed
pubmed-article:19773176pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19773176pubmed:citationSubsetIMlld:pubmed
pubmed-article:19773176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19773176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19773176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19773176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19773176pubmed:statusMEDLINElld:pubmed
pubmed-article:19773176pubmed:monthOctlld:pubmed
pubmed-article:19773176pubmed:issn1464-3391lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:BeraldoHelois...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:Souza-Fagunde...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:SpezialiNival...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:MendesIsolda...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:FerrazKarina...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:FerandesLucas...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:CarrilhoDiego...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:PintoMauro...lld:pubmed
pubmed-article:19773176pubmed:authorpubmed-author:LeiteMaria...lld:pubmed
pubmed-article:19773176pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19773176pubmed:day15lld:pubmed
pubmed-article:19773176pubmed:volume17lld:pubmed
pubmed-article:19773176pubmed:ownerNLMlld:pubmed
pubmed-article:19773176pubmed:authorsCompleteYlld:pubmed
pubmed-article:19773176pubmed:pagination7138-44lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:meshHeadingpubmed-meshheading:19773176...lld:pubmed
pubmed-article:19773176pubmed:year2009lld:pubmed
pubmed-article:19773176pubmed:articleTitle2-Benzoylpyridine-N(4)-tolyl thiosemicarbazones and their palladium(II) complexes: cytotoxicity against leukemia cells.lld:pubmed
pubmed-article:19773176pubmed:affiliationDepartamento de Química, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Brazil.lld:pubmed
pubmed-article:19773176pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19773176pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:19773176lld:chembl